REZUROCK is undoubtedly an inhibitor of UGT1A1. Coadministration of REZUROCK with a UGT1A1 substrate decreased plasma concentrations of the glucuronide metabolite, which can increase the possibility of adverse reactions relevant to sensitive substrates of UGT1A1 Being an Affiliate Publisher or Pu